Influence of the Women's Health Initiative trial on the practice of prophylactic oophorectomy and the prescription of estrogen therapy.

Physicians have become more conservative regarding prophylactic oophorectomy after publication of the Women's Health Initiative trial. They are less likely to prescribe estrogen therapy for women who have a high risk of coronary heart disease and more likely to use nonoral routes for estrogen therapy.